Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TruScreen Group Ltd. (AU:TRU)
ASX:TRU
RESEARCH TOOLSreports
TruScreen Group Ltd. (TRU) Share Price & Analysis
0 Followers
TRU Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.01 - AU$0.03
Previous CloseAU$0.02
Volume252.89K
Average Volume (3M)121.21K
Market Cap
AU$10.08M
Enterprise ValueAU$7.57M
Total Cash (Recent Filing)$2.80M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.11
Next Earnings
Nov 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume121,211
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TruScreen Group Ltd. News
PremiumCompany Announcements
TruScreen Advances Cervical Screening in Vietnam
PremiumCompany Announcements
TruScreen Unveils 2024 Annual Report Highlights
PremiumCompany Announcements
TruScreen Reports Revenue Surge and Strategic Growth
PremiumCompany Announcements
TruScreen Advances Global Market PenetrationOptions Prices
Currently, No data available
---
Ownership Overview
5.86% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
94.14% Public Companies and
Individual Investors
TRU FAQ
What was TruScreen Group Ltd.’s price range in the past 12 months?
TruScreen Group Ltd. lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.
What is TruScreen Group Ltd.’s market cap?
Currently, no data Available
When is TruScreen Group Ltd.’s upcoming earnings report date?
TruScreen Group Ltd.’s upcoming earnings report date is Nov 27, 2024 which is in 126 days.
How were TruScreen Group Ltd.’s earnings last quarter?
TruScreen Group Ltd. released its earnings results on May 29, 2024. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is TruScreen Group Ltd. overvalued?
According to Wall Street analysts TruScreen Group Ltd.’s price is currently Overvalued.
Does TruScreen Group Ltd. pay dividends?
TruScreen Group Ltd. does not currently pay dividends.
What is TruScreen Group Ltd.’s EPS estimate?
TruScreen Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TruScreen Group Ltd. have?
TruScreen Group Ltd. has 560,033,600 shares outstanding.
What happened to TruScreen Group Ltd.’s price movement after its last earnings report?
TruScreen Group Ltd. reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of TruScreen Group Ltd.?
Currently, no hedge funds are holding shares in AU:TRU
---
TruScreen Group Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:TRU Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.00%
12-Months-Change
Fundamentals
Return on Equity
-71.16%
Trailing 12-Months
Asset Growth
13.99%
Trailing 12-Months
Company Description
TruScreen Group Ltd.
Truscreen Group Ltd is engaged in providing real-time, accurate detection of pre-cancerous and cancerous cervical cells to help improve the health and well-being of women around the world. The company holds a right to the Truscreen Cervical Cancer screening system which comprises a medical device and process designed to detect the presence in real time of precancerous and cancerous tissue on the cervix. Its product, Truscreen utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. The company operates its business in New Zealand, Mexico, China, Russia, Iran, Turkey and other.
---
Technical Analysis
LBT Innovations Limited
―
MedAdvisor Limited
―
Integral Diagnostics Ltd.
―
Resonance Health Ltd
―
---